You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. New Diagnostics for Amebiasis

    SBC: TECHLAB, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): Entamoeba histolytica, the cause of amoebiasis, is a Category B pathogen considered in the top three biodefense parasites because it is difficult to diagnose. The disease caused by this protozoan pathogen occurs du

    SBIR Phase I 2004 Department of Health and Human ServicesNational Institutes of Health
  2. A2A Adenosine Receptor Agonist for the Treatment of IBD

    SBC: ADENOSINE THERAPEUTICS, LLC            Topic: N/A

    DESCRIPTION (provided by applicant): Adenosine Therapeutics, LLC (ATL) is a biotechnology company started in Charlottesville, Virginia in 1999. ATL owns patents on the formulation and use of a family of potent and highly selective agonists of A2A adenosin

    SBIR Phase I 2004 Department of Health and Human ServicesNational Institutes of Health
  3. PREDICTABLE REAL-TIME MULTIPROCESSING IN AIRBORNE SYSTEMS

    SBC: Unisoft Consulting Inc            Topic: N/A

    N/A

    SBIR Phase I 1996 National Aeronautics and Space Administration
  4. SECONDARY PREVENTION OF ALCOHOLISM VIA COMPUTER SOFTWARE

    SBC: Alcohol Self-control Program            Topic: N/A

    N/A

    SBIR Phase I 1990 Department of Health and Human Services
  5. Scintillation Luminescence System for In-Vivo Dosimetry

    SBC: Nomadics, Inc.            Topic: N/A

    DESCRIPTION (provided by applicant): Nomadics proposes the development of scintillation nanocomposite materials that are capable of producing scintillation luminescence (SL) and the demonstration of their applicability for in vivo dosimetry and radiati

    SBIR Phase I 2004 Department of Health and Human ServicesNational Institutes of Health
  6. PEGylation of a Glycosulfopeptide Anti-Inflammatory

    SBC: SELEXYS PHARMACEUTICALS CORPORATION            Topic: N/A

    DESCRIPTION (provided by applicant): Normal recruitment of circulating white blood cells (leukocytes) into tissues is important in inflammation, lymphocyte homing, and immunological responses. The mechanism of recruitment involves receptors termed se

    SBIR Phase I 2004 Department of Health and Human ServicesNational Institutes of Health
  7. Noninvasive skin spectroscopy for diabetes screening

    SBC: INLIGHT SOLUTIONS, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): InLight Solutions' objective is to develop and commercialize an optical system for diabetes screening and disease monitoring. This system is intended to noninvasively and accurately quantify the advanced glycation end products in a subject's skin and provide the physician with this quantitative information in order to make diagnostic and therapeutic decision ...

    STTR Phase I 2004 Department of Health and Human ServicesNational Institutes of Health
  8. Noninvasive skin spectroscopy for diabetes screening

    SBC: INLIGHT SOLUTIONS, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): InLight Solutions' objective is to develop and commercialize an optical system for diabetes screening and disease monitoring. This system is intended to noninvasively and accurately quantify the advanced glycation e

    SBIR Phase I 2004 Department of Health and Human ServicesNational Institutes of Health
  9. Lung tumor detection using biomagnetic imaging

    SBC: FELDMATECH, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): Lung career in the United States is one of the leading causes of death, with 177,000 new cases yearly, resulting in a death rate of 158,000 people per year (1,2). There are more deaths from lung cancer than from prostate, breast and colorectal cancers combined. Unfortunately, the vast majority of lung tumors re clinically silent until the disease is termina ...

    STTR Phase I 2004 Department of Health and Human ServicesNational Institutes of Health
  10. Lung tumor detection using biomagnetic imaging

    SBC: FELDMATECH, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): Lung career in the United States is one of the leading causes of death, with 177,000 new cases yearly, resulting in a death rate of 158,000 people per year (1,2). There are more deaths from lung cancer than from pro

    SBIR Phase I 2004 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government